Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: DaVita (DVA) and Immunocore Holdings (IMCR)

Tipranks - Tipranks - Thu Feb 5, 5:54AM CST

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on DaVita (DVA – Research Report) and Immunocore Holdings (IMCR – Research Report) with bullish sentiments.

Claim 50% Off TipRanks Premium

DaVita (DVA)

UBS analyst A.J. Rice maintained a Buy rating on DaVita today and set a price target of $190.00. The company’s shares closed last Tuesday at $134.73.

According to TipRanks.com, Rice is a 5-star analyst with an average return of 7.9% and a 60.0% success rate. Rice covers the Healthcare sector, focusing on stocks such as Ardent Health Partners, Inc., Aveanna Healthcare Holdings, and Cross Country Healthcare. ;'>

DaVita has an analyst consensus of Hold, with a price target consensus of $164.00.

See the top stocks recommended by analysts >>

Immunocore Holdings (IMCR)

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Immunocore Holdings today and set a price target of $100.00. The company’s shares closed last Tuesday at $32.07, close to its 52-week low of $27.19.

According to TipRanks.com, Trucchio is a 5-star analyst with an average return of 32.0% and a 53.4% success rate. Trucchio covers the Healthcare sector, focusing on stocks such as Harmony Biosciences Holdings, Arrowhead Pharmaceuticals, and Alto Neuroscience, Inc. ;'>

Currently, the analyst consensus on Immunocore Holdings is a Strong Buy with an average price target of $65.13.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).